The research sheds new light on how this enzyme influences glucagon secretion in pancreatic alpha (α) cells, a process crucial ... in people with type 2 diabetes (T2D), glucagon levels are ...

Septerna has a market cap of $750mn and $130mn in cash and ST investments. Discover SEPN's groundbreaking drug discovery ...

Eli Lilly and Company's impressive Q4 earnings driven by tirzepatide's success, diverse portfolio, and promising pipeline.

Intermittent fasting is becoming increasingly popular. But is it helpful for weight loss and other medical conditions?

Glucagon, produced by alpha (α) cells in the pancreas, works in tandem with insulin to maintain blood sugar balance. When blood sugar drops too low, glucagon raises it, ensuring stability. However, ...

Targeting mitochondrial retrograde signaling may therefore be promising in the treatment or prevention of metabolic disorders ...

Allogene Therapeutics (ALLO) announced the publication of data from its Phase 1 ALPHA and ALPHA2 clinical studies of cemacabtagene ...

The study enrolled 3533 participants with T2D and CKD (defined as eGFR 25 to 75mL/min/1.73m 2 and urinary albumin-to-creatinine ratio [UACR] >100 and <5000mg/g). Study participants were randomly ...

Opens in a new tab or window AURORA, Colo. -- Pregnant patients with type 2 diabetes (T2D) treated with semaglutide (Ozempic) had mixed pregnancy outcomes, an observational study found.